Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents

This study has been completed.
Sponsor:
Collaborator:
Aeras
Information provided by:
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00950612
First received: July 23, 2009
Last updated: June 23, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: December 24, 2010